Yossi Benamram, President

Professional Overview

Yossi Benamram is a seasoned global pharmaceutical executive with over 30 years of experience driving strategic initiatives and business development across international markets. As the President of Quris-AI and serving on the boards of several leading biotech and healthcare organizations, Yossi leverages his deep industry expertise and strong track record of success to propel innovation and growth in the life sciences sector.

Experience Summary

Current Role

President, Quris-AI (2023-06-01 to Present)

Providing strategic direction and oversight for the development and commercialization of Quris-AI's proprietary AI-powered drug discovery platform

Spearheading partnerships and collaborations with leading pharmaceutical and biotechnology companies to advance novel therapeutic solutions

Championing the adoption of cutting-edge technologies to streamline drug development and improve patient outcomes

Board Member, PharOS Ltd. (2024-11-01 to Present)

Providing strategic guidance and oversight to the board on the company's digital health initiatives and the development of its innovative healthcare technology solutions

Board Member, PolyPid Ltd. (2023-05-01 to Present)

Leveraging expertise to support the company's efforts in advancing its pipeline of novel drug delivery systems and therapeutic solutions

Co-Founder & CSO, Golden Age Health Bioventures (2023-03-01 to Present)

Driving the strategic vision and overseeing the development of the company's portfolio of innovative healthcare solutions targeting the aging population

Senior Investment Advisor, Armira (2023-01-01 to Present)

Providing expert guidance and insights to the firm's investment team on identifying high-potential opportunities in the life sciences and healthcare sectors

Career Progression

Co-Founder & Chairman of the Board, MediCane Health Incorporated (2022-09-01 to Present)

Spearheaded the founding and growth of MediCane, a leading provider of medical cannabis solutions, serving as CEO from 2019 to 2022

Senior Business Advisor, Aposense (2021-05-01 to Present)

Providing strategic counsel and subject matter expertise to support the company's ongoing drug development initiatives

Independent Global Pharma Executive, YBA Global Consulting LTD (2019-03-01 to Present)

Offering strategic advisory services and cross-functional expertise to help pharmaceutical and biotechnology companies navigate complex global markets

President, EURAM Region (Europe, Russia, Africa, Middle East), MSD (2017-10-01 to 2019-02-01)

Directed the company's operations and growth strategies across the EURAM region, driving revenue and market share expansion

President, Mid Europe Region, MSD (2016-06-01 to 2017-09-01)

Provided executive leadership to MSD's operations in the Mid Europe region, spearheading key initiatives to enhance operational efficiency and profitability

Academic Background

Master of Business Administration (MBA), Tel Aviv University, Israel

Bachelor of Science (B.Sc.) in Pharmacy, Hebrew University of Jerusalem, Israel

Areas of Expertise

Global pharmaceutical and biotechnology industry

Drug development and commercialization

Strategic business planning and execution

Mergers, acquisitions, and strategic partnerships

Emerging market expansion and growth strategies

Digital health and AI-powered drug discovery

Professional Impact

Instrumental in the successful founding and scaling of MediCane Health, a leading provider of medical cannabis solutions

Served in senior leadership roles at Merck (MSD), overseeing the company's operations and growth strategies across key international markets

Recognized as a thought leader in the pharmaceutical and biotechnology industries, actively contributing to industry events and publications

Serves on the boards of several prominent life sciences and healthcare organizations, providing strategic guidance and oversight

Conclusion

With his extensive experience, deep industry expertise, and proven track record of driving innovation and business growth, Yossi Benamram is a respected global pharmaceutical executive poised to make a significant impact in the rapidly evolving life sciences and healthcare landscape. As he continues to serve in key leadership roles, Yossi remains committed to leveraging cutting-edge technologies, fostering strategic partnerships, and championing the development of transformative healthcare solutions that improve patient outcomes worldwide.